Chuhan Chung Selected Research

firsocostat

1/2022	Fenofibrate Mitigates Hypertriglyceridemia in Nonalcoholic Steatohepatitis Patients Treated With Cilofexor/Firsocostat.
1/2021	Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH.
12/2018	Acetyl-CoA Carboxylase Inhibitor GS-0976 for 12 Weeks Reduces Hepatic De Novo Lipogenesis and Steatosis in Patients With Nonalcoholic Steatohepatitis.
11/2018	GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chuhan Chung Research Topics

Disease

14	Fibrosis (Cirrhosis) 01/2022 - 03/2013
8	Non-alcoholic Fatty Liver Disease 01/2022 - 11/2018
7	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 04/2011
6	Neoplasms (Cancer) 10/2016 - 09/2006
4	type 6 Osteogenesis imperfecta 01/2016 - 11/2013
3	Pruritus (Itching) 06/2022 - 01/2020
3	Sclerosing Cholangitis 06/2022 - 01/2019
3	Carcinoma in Situ 10/2016 - 05/2011
3	Pancreatic Neoplasms (Pancreatic Cancer) 05/2016 - 05/2011
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2014 - 12/2012
2	Insulin Resistance 01/2022 - 12/2012
2	Liver Diseases (Liver Disease) 01/2022 - 11/2002
2	Inflammation (Inflammations) 01/2021 - 05/2016
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2020 - 01/2019
2	Osteogenesis Imperfecta (Lobstein Disease) 01/2016 - 11/2013
2	Hepatocellular Carcinoma (Hepatoma) 01/2015 - 01/2008
2	Hepatic Encephalopathy 09/2003 - 01/2003
2	Brain Edema (Cerebral Edema) 08/2003 - 08/2003
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 06/2022
1	Hypertriglyceridemia 01/2022
1	Portal Hypertension 12/2021
1	Disease Progression 01/2021
1	Cholangitis 02/2020
1	Fatty Liver 01/2020
1	Cholestasis 01/2019
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2017
1	Cicatrix (Scar) 07/2016
1	Carcinogenesis 05/2016
1	Multiple Fractures 12/2015
1	Rare Diseases (Rare Disease) 12/2015
1	Bone Diseases (Bone Disease) 12/2015
1	Hyperglycemia 04/2014
1	Diabetes Mellitus 12/2012
1	Hypertrophy 10/2012
1	Pancreatitis 12/2011
1	Adenocarcinoma 05/2011
1	Hepatoblastoma 09/2006
1	Hyperemia 12/2004

Drug/Important Bio-Agent (IBA)

11	pigment epithelium-derived factorIBA 10/2016 - 09/2006
8	Proteins (Proteins, Gene)FDA Link 01/2017 - 11/2013
6	CollagenIBA 01/2022 - 05/2016
5	Biomarkers (Surrogate Marker)IBA 06/2022 - 11/2018
5	cilofexorIBA 06/2022 - 01/2019
4	firsocostatIBA 01/2022 - 11/2018
4	Bile Acids and Salts (Bile Acids)IBA 01/2021 - 01/2019
4	CateninsIBA 10/2016 - 11/2014
4	AmmoniaIBA 12/2004 - 01/2003
3	Alanine Transaminase (SGPT)IBA 01/2022 - 02/2020
3	Insulin (Novolin)FDA Link 01/2021 - 12/2012
2	Triglycerides (Triacylglycerol)IBA 01/2022 - 01/2022
2	Acetyl-CoA CarboxylaseIBA 01/2022 - 12/2018
2	selonsertibIBA 01/2022 - 01/2021
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2021 - 01/2021
2	BilirubinIBA 12/2021 - 01/2021
2	Biological ProductsIBA 01/2021 - 12/2015
2	Alkaline PhosphataseIBA 01/2021 - 02/2020
2	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 02/2020 - 01/2019
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 02/2020 - 01/2020
2	CytokinesIBA 05/2016 - 12/2011
2	CeruletideIBA 05/2016 - 12/2011
2	Adenosine Triphosphatases (ATPase)IBA 11/2014 - 05/2011
2	Matrix Metalloproteinases (MMPs)IBA 10/2012 - 05/2011
1	Fenofibrate (CiL)FDA LinkGeneric 01/2022
1	simtuzumabIBA 01/2022
1	O(4)-methylthymidine triphosphateIBA 01/2022
1	Lipoproteins (Lipoprotein)IBA 01/2022
1	VLDL LipoproteinsIBA 01/2022
1	PalmitatesIBA 01/2022
1	Deuterium Oxide (Heavy Water)IBA 01/2022
1	4-(3-chlorophenylsulfanyl)piperidineIBA 12/2021
1	Interleukin-8 (Interleukin 8)IBA 01/2021
1	Keratin-18 (Keratin 18)IBA 01/2021
1	nasIBA 01/2021
1	Drug CombinationsIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Tissue Inhibitor of Metalloproteinase-1IBA 11/2018
1	Protons (Proton)IBA 11/2018
1	LigandsIBA 10/2016
1	Wnt3A ProteinIBA 10/2016
1	Glycoproteins (Glycoprotein)IBA 10/2016
1	IntegrinsIBA 07/2016
1	Peptides (Polypeptides)IBA 01/2015
1	Low Density Lipoprotein Receptor-Related Protein-6IBA 01/2015
1	MineralsIBA 11/2013
1	Carbon Tetrachloride (Tetrachloromethane)IBA 03/2013
1	Glucose (Dextrose)FDA LinkGeneric 12/2012
1	SerpinsIBA 10/2012
1	Ethanol (Ethyl Alcohol)IBA 12/2011
1	CortactinIBA 05/2011
1	Vacuolar Proton-Translocating ATPases (V-Type ATPase)IBA 05/2011
1	Protein Isoforms (Isoforms)IBA 05/2011
1	salicylhydroxamic acid (SHAM)IBA 04/2011
1	EnzymesIBA 01/2008
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2008
1	beta-Galactosidase (Lactaid)IBA 09/2006
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2006

Therapy/Procedure

3	Therapeutics 06/2022 - 01/2021
2	Transplantation 02/2020 - 11/2002
2	Surgical Portacaval Shunt (Portacaval Anastomosis) 12/2004 - 08/2003
1	Ligation 04/2011